about
Essential thrombocytemia and acute coronary syndrome: clinical profile and association with other thromboembolic eventsEstimation of diagnosis and prognosis in ET by assessment of CALR and JAK2V617F mutations and laboratory findings: a meta-analysis.Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up reportPostpartal recurrent non-ST elevation myocardial infarction in essential thrombocythaemia: case report and review of the literature.Circulating endothelial cells in patients with venous thromboembolism and myeloproliferative neoplasms.A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia.Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia.Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?Essential thrombocythemia in a young man treated for myocardial infarction.The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment.Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.[Differential diagnosis of myeloproliferative neoplasms. Quantitative NF-E2 immunohistochemistry for differentiating between essential thrombocythemia and primary myelofibrosis].
P2860
Q28222363-13A66816-6CEA-4910-B6F2-7A27AACE2CE6Q30235926-EB7B0346-6D0B-4349-BA4B-37EE9A2761F1Q33968801-D2569C68-8157-4E9E-912A-29FAF04CDAF6Q34016598-27DC108A-7739-4AFF-9AAA-A40E44C2EE12Q35067553-A24CA5DB-4FCA-48FB-AEED-FCF07957C08CQ36717896-AAB6369F-DAA0-4624-BE31-CDCCCFE2B45DQ36857937-12D624BD-E57C-4A4E-91AA-76830FEEEF76Q36857952-2C328B87-D3E4-4AAB-854F-3F732A7DFCF2Q36941052-CB51CE92-0CEE-45A3-A30F-4EF6BD31BC02Q36983755-B8BE646A-79C3-48C7-A712-267F7A351487Q37275858-B60951DB-E270-4EED-9C74-969EC32C64A4Q42584239-D3A4A90B-DB4B-4266-9B76-6EC89AD979CBQ44394903-368B6B2A-EE20-487E-8AC6-79A047DBC0B1Q46364019-DCA6093F-C29E-43AA-850F-9131B40BA0E3Q54611640-96A81BAB-8D39-4E8D-89C0-ECE6068F87A3
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
When and how to treat essential thrombocythemia
@ast
When and how to treat essential thrombocythemia
@en
When and how to treat essential thrombocythemia
@nl
type
label
When and how to treat essential thrombocythemia
@ast
When and how to treat essential thrombocythemia
@en
When and how to treat essential thrombocythemia
@nl
prefLabel
When and how to treat essential thrombocythemia
@ast
When and how to treat essential thrombocythemia
@en
When and how to treat essential thrombocythemia
@nl
P356
P1476
When and how to treat essential thrombocythemia
@en
P2093
Guido Finazzi
Tiziano Barbui
P356
10.1056/NEJME058093
P407
P577
2005-07-07T00:00:00Z